Last Updated: November 16, 2026

Investigational Drug Information for Centhaquine

« Back to Dashboard


What is the drug development status for Centhaquine?

Centhaquine is an investigational drug.

There have been 5 clinical trials for Centhaquine. The most recent clinical trial was a Phase 3 trial, which was initiated on August 13th 2021.

The most common disease conditions in clinical trials are Hypovolemia, Shock, and Hemorrhage. The leading clinical trial sponsors are Pharmazz, Inc. and [disabled in preview].

There is one US patent protecting this investigational drug.

Recent Clinical Trials for Centhaquine
TitleSponsorPhase
Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in COVID-19 Patients With ARDSPharmazz, Inc.Phase 2
A Phase-III Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative AgentPharmazz, Inc.Phase 3
A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock PatientsPharmazz, Inc.PHASE4

See all Centhaquine clinical trials

Clinical Trial Summary for Centhaquine

Top disease conditions for Centhaquine
Top clinical trial sponsors for Centhaquine

See all Centhaquine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.